INO peer analysis
Inovio (INO) against its competitors: price, today's move, 1-year return and market value side by side.
INO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals | $0.21 | -90.83% | -90.54% | – |
| ACTU Actuate Therapeutics | $0.34 | -9.68% | -94.91% | – |
| AGEN Agenus | $6.84 | -3.53% | 79.53% | $320.20M |
| ALEC Alector | $2.19 | -0.90% | 44.08% | $250.11M |
| FATE Fate Therapeutics | $2.08 | -4.15% | 61.24% | $260.01M |
| IRD Opus Genetics | $3.67 | 0.55% | 86.29% | – |
| MCRB Seres Therapeutics | $1.77 | -9.23% | -88.78% | $19.59M |
| SEER Seer | $1.68 | -13.40% | -24.66% | – |
| SPRO Spero Therapeutics | $1.06 | -4.50% | -55.08% | $64.64M |
| VTGN Vistagen Therapeutics | $0.17 | -1.41% | -95.51% | $7.58M |
| INO Inovio | $2.16 | 258.57% | -10.17% | $79.80M |
- INO's peers: ABOS (Acumen Pharmaceuticals), ACTU (Actuate Therapeutics), AGEN (Agenus), ALEC (Alector), FATE (Fate Therapeutics), IRD (Opus Genetics), MCRB (Seres Therapeutics), SEER (Seer).
Updated 2026-11-02 17:53 UTC